Bank of Jackson Hole Trust Purchases Shares of 404 GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Bank of Jackson Hole Trust purchased a new stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC) in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund purchased 404 shares of the company’s stock, valued at approximately $32,000.

Several other hedge funds and other institutional investors have also recently bought and sold shares of GEHC. D1 Capital Partners L.P. bought a new stake in GE HealthCare Technologies in the third quarter valued at $268,159,000. Van ECK Associates Corp increased its stake in GE HealthCare Technologies by 107.3% in the fourth quarter. Van ECK Associates Corp now owns 4,841,652 shares of the company’s stock valued at $378,520,000 after purchasing an additional 2,506,417 shares in the last quarter. State Street Corp increased its position in shares of GE HealthCare Technologies by 7.8% during the third quarter. State Street Corp now owns 18,615,890 shares of the company’s stock worth $1,747,101,000 after acquiring an additional 1,347,114 shares in the last quarter. Massachusetts Financial Services Co. MA bought a new stake in shares of GE HealthCare Technologies during the third quarter worth about $93,713,000. Finally, Jennison Associates LLC increased its position in shares of GE HealthCare Technologies by 124.5% during the fourth quarter. Jennison Associates LLC now owns 1,709,635 shares of the company’s stock worth $133,659,000 after acquiring an additional 948,017 shares in the last quarter. 82.06% of the stock is owned by institutional investors.

GE HealthCare Technologies Stock Down 0.5 %

GE HealthCare Technologies stock opened at $92.09 on Friday. GE HealthCare Technologies Inc. has a fifty-two week low of $74.51 and a fifty-two week high of $94.80. The stock has a market cap of $42.11 billion, a PE ratio of 21.27, a price-to-earnings-growth ratio of 3.21 and a beta of 1.15. The firm’s 50-day simple moving average is $84.85 and its 200 day simple moving average is $85.76. The company has a debt-to-equity ratio of 0.88, a quick ratio of 0.83 and a current ratio of 1.04.

GE HealthCare Technologies (NASDAQ:GEHC) last released its earnings results on Thursday, February 13th. The company reported $1.45 earnings per share for the quarter, beating analysts’ consensus estimates of $1.26 by $0.19. The firm had revenue of $5.32 billion for the quarter, compared to analysts’ expectations of $5.33 billion. GE HealthCare Technologies had a net margin of 10.13% and a return on equity of 25.74%. Research analysts predict that GE HealthCare Technologies Inc. will post 4.68 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently commented on the stock. Jefferies Financial Group raised shares of GE HealthCare Technologies from a “hold” rating to a “buy” rating and boosted their target price for the stock from $95.00 to $103.00 in a research report on Wednesday, January 8th. Citigroup boosted their target price on shares of GE HealthCare Technologies from $103.00 to $110.00 and gave the stock a “buy” rating in a research report on Thursday, February 13th. Finally, Wells Fargo & Company boosted their target price on shares of GE HealthCare Technologies from $96.00 to $103.00 and gave the stock an “overweight” rating in a research report on Friday, February 14th. One analyst has rated the stock with a sell rating, three have assigned a hold rating, eight have issued a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $97.67.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.